FTSE Russell e-therapeutics

RNS Number : 2162N

FTSE Russell

03 May 2024

E-therapeutics (UK): Constituent Deletion
Changes in FTSE UK Index Series

03 May 2024

Subject to the expected cancellation of trading on AIM for E-therapeutics (UK, constituent), please see details of affected indexes and effective dates below:

Index	Effective From Start of Trading
FTSE AIM All-Share Index	09 May 2024

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia	+61 (0) 2 7228 5659
Hong Kong	+852 2164 3333
Japan	+81 3 6441 1430
London	+44 (0) 20 7866 1810
New York	+1877 503 6437

Alternatively please visit our website at lseg.com/ftse-russell

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FTSBBGDUGBGDGSX

E-therapeutics (LSE:ETX)
Historical Stock Chart
From Oct 2024 to Nov 2024